NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Open Orphan plc (LSE: ORPH)

 
ORPH Technical Analysis
5
As on 25th Oct 2022 ORPH STOCK Price closed @ 10.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 22.73 & Strong Sell for SHORT-TERM with Stoploss of 31.72 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ORPHSTOCK Price

Open 9.50 Change Price %
High 10.38 1 Day 0.50 5.26
Low 9.50 1 Week 0.60 6.38
Close 10.00 1 Month 0.00 0.00
Volume 652639 1 Year -26.80 -72.83
52 Week High 39.00 | 52 Week Low 8.75
 
LSE UK Most Active Stocks
UKOG 0.01 0.00%
PREM 0.01 0.00%
VRS 0.02 0.00%
MIRI 0.01 0.00%
TRP 0.03 %
ENET 0.02 0.00%
DEMG 0.02 -50.00%
MSMN 0.02 0.00%
TIR 0.34 -17.07%
SMDS 582.50 0.00%
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
SSIF 18.50 208.33%
ARB 2.10 121.05%
ARB 2.10 121.05%
ARB 2.10 121.05%
CGW 55.03 107.66%
GILD 0.08 100.00%
GILD 0.08 100.00%
GILD 0.08 100.00%
CNN 65.00 85.71%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
ORPH
Daily Charts
ORPH
Intraday Charts
Whats New @
Bazaartrend
ORPH
Free Analysis
 
ORPH Important Levels Intraday
RESISTANCE11.70
RESISTANCE11.15
RESISTANCE10.82
RESISTANCE10.48
SUPPORT9.52
SUPPORT9.18
SUPPORT8.85
SUPPORT8.30
 
ORPH Forecast July 2025
4th UP Forecast30.23
3rd UP Forecast23.74
2nd UP Forecast19.73
1st UP Forecast15.72
1st DOWN Forecast4.28
2nd DOWN Forecast0.27
3rd DOWN Forecast-3.74
4th DOWN Forecast-10.23
 
ORPH Weekly Forecast
4th UP Forecast20.60
3rd UP Forecast17.20
2nd UP Forecast15.10
1st UP Forecast13.00
1st DOWN Forecast7.00
2nd DOWN Forecast4.90
3rd DOWN Forecast2.80
4th DOWN Forecast-0.60
 
ORPH Forecast2025
4th UP Forecast70.35
3rd UP Forecast51
2nd UP Forecast39.03
1st UP Forecast27.07
1st DOWN Forecast-7.07
2nd DOWN Forecast-19.03
3rd DOWN Forecast-31
4th DOWN Forecast-50.35
 
 
ORPH Other Details
Segment EQ
Market Capital 134170992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ORPH Address
ORPH
 
ORPH Latest News
 
Your Comments and Response on Open Orphan plc
 
ORPH Business Profile
Open Orphan plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to Big Pharma, biotech, government, and public health organizations. The company has a portfolio of eight human challenge study models for conditions, such as RSV, flu, asthma and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company is headquartered in London, the United Kingdom. Address: 10-12 Alie Street, London, United Kingdom, E1 8DE
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service